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Background: An unprecedented number of nationwide tuberculosis (TB) prevalence surveys will be implemented
between 2010 and 2015, to better estimate the burden of disease caused by TB and assess whether global targets
for TB control set for 2015 are achieved. It is crucial that results are analysed using best-practice methods.
Objective: To provide new theoretical and practical guidance on best-practice methods for the analysis of TB
prevalence surveys, including analyses at the individual as well as cluster level and correction for biases arising from
missing data.
Analytic methods: TB prevalence surveys have a cluster sample survey design; typically 50-100 clusters are
selected, with 400-1000 eligible individuals in each cluster. The strategy recommended by the World Health
Organization (WHO) for diagnosing pulmonary TB in a nationwide survey is symptom and chest X-ray screening,
followed by smear microscopy and culture examinations for those with an abnormal X-ray and/or TB symptoms.
Three possible methods of analysis are described and explained. Method 1 is restricted to participants, and
individuals with missing data on smear and/or culture results are excluded. Method 2 includes all eligible
individuals irrespective of participation, through multiple missing value imputation. Method 3 is restricted to
participants, with multiple missing value imputation for individuals with missing smear and/or culture results, and
inverse probability weighting to represent all eligible individuals. The results for each method are then compared
and illustrated using data from the 2007 national TB prevalence survey in the Philippines. Simulation studies are
used to investigate the performance of each method.
Key findings: A cluster-level analysis, and Methods 1 and 2, gave similar prevalence estimates (660 per 100,000
aged ≥ 10 years old), with a higher estimate using Method 3 (680 per 100,000). Simulation studies for each of 4
plausible scenarios show that Method 3 performs best, with Method 1 systematically underestimating TB
prevalence by around 10%.
Conclusion: Both cluster-level and individual-level analyses should be conducted, and individual-level analyses
should be conducted both with and without multiple missing value imputation. Method 3 is the safest approach to
correct the bias introduced by missing data and provides the single best estimate of TB prevalence at the
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National population-based surveys of the prevalence
of pulmonary tuberculosis (TB) disease in adults can
be used to measure the burden of disease caused by
TB, to measure trends in this burden when repeat
surveys are performed and to understand why people
with TB have not been detected or diagnosed by na-
tional TB control programmes (NTPs). Surveys are of
greatest relevance in countries with a high burden of
TB in which surveillance data capture much less than
100% of cases. Global targets for reductions in disease
burden set for 2015 include halving prevalence rates
compared with their level in 1990; the other targets
are that mortality rates should be halved between
1990 and 2015, and that TB incidence should be fall-
ing by 2015 [1].
The Global Task Force on TB Impact Measurement
is hosted by the World Health Organization (WHO)
with a mandate to ensure the best-possible assess-
ment of whether 2015 global targets for reductions in
TB disease burden are achieved [2]. The Task Force
has strongly recommended national TB prevalence
surveys in 22 global focus countries in the years lead-
ing up to 2015 [3,4]. Since 2008, there has been an
unprecedented increase in the number of countries
either implementing or planning to implement na-
tionwide surveys. Between 2009 and 2015, approxi-
mately 23 countries - including 20 of the global focus
countries - are expected to implement a survey, com-
pared with a total of 7 countries in the period 2002–
2007 (Figure 1). Only four countries, all in Asia,
implemented surveys between 1990 and 2001. The
global investment in prevalence surveys will amount
to around US$ 50 million between 2010 and 2015.Figure 1 Global progress with nationwide prevalence surveys of TB d
nationwide surveys of the prevalence of TB disease, actual (2002–2012) andAnalysis of results using best-practice methods is
crucial.
TB prevalence surveys have a cluster sample survey
design, in which groups of individuals are sampled,
with clusters selected at random from an area sam-
pling frame with probability proportional to size
(PPS). While the classic method of using each survey
cluster as the unit of analysis has been carefully and
thoroughly described for a TB prevalence survey
[5,6], methods to implement an individual-level ana-
lysis, in which each eligible adult enumerated in the
survey is the unit of analysis, have not. An
individual-level analysis is valuable because it enables
adjustment for differences between participants and
non-participants and multiple imputation of missing
data, while simultaneously allowing for clustering in
the sampling design. Missing data in TB prevalence
surveys can be observed in both the outcome (TB
case or not) but also other covariates, for example
due to non-participation of eligible individuals, un-
availability of screening or diagnostic results due to
human error, and loss of specimens at laboratories
for reasons such as contamination. A prevalence esti-
mate based on only individuals with complete data
will be biased, except under the strong assumption
that those with and without full information have the
same prevalence of TB. Methods that incorporate
missing value imputation are thus important for two
reasons: to obtain a more valid estimate of pulmon-
ary TB prevalence, and to assess the bias of simpler
analytical approaches [7,8]. Moreover, while participa-
tion rates in recent surveys in Asia have been very
high, the rates achieved in other surveys from 2012
onwards may be lower; accounting for missing dataisease. Global progress in implementing field operations of
expected (2013–2017).
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results.
Findings from national TB prevalence surveys com-
pleted in 2007 in the Philippines and Viet Nam have
been published [9,10]. Other national surveys have
either not followed the screening strategy now
recommended by WHO [11,12], or the results have
been disseminated in a survey report but not in a
scientific journal. The analysis of the Philippines sur-
vey attempted to account for missing data using
within-cluster mean imputation, stratified on age and
sex, but did not include individual-level analysis. The
analysis of the Vietnam survey used an individual-level
analysis but did not formally account for missing data on
smear and culture results, or age and sex differences be-
tween participants and non-participants.
This paper (outlined in Figure 2) provides new the-
oretical and practical guidance on best-practice
methods for analysis of data from a TB prevalence
survey, notably methods for individual-level analyses
that account for the cluster sample survey design
and that allow correction for biases due to missing
data. Methods are described and explained, and then
illustrated and compared using data from the 2007
survey in the Philippines. We draw on materialFigure 2 Paper outline.previously developed in 2010 by the authors in a
WHO handbook [4] but provide much more explan-
ation of the underlying principles and methods re-
quired to implement multiple imputation of missing
data. This includes guidance based on insights gained
in 2011 and 2012 through the analysis of prevalence
surveys conducted in Myanmar (2010) [13], Ethiopia
(2010/11) [14], and Cambodia (2010/11) [15]. We
also place the analytical methods within a new con-
ceptual framework [16,17].
Methods
Survey design and summary of key data: an overview
For on-going and future TB prevalence surveys, the
eligible population is defined as individuals aged
≥15 years old who were already resident in the se-
lected cluster at the time of the survey team’s first
pre-survey visit [4]. Individuals <15 years old are ex-
cluded, because of the difficulties in diagnosing pul-
monary TB in children. Cluster size is recommended
to be between 400 and 1000 eligible individuals, with
the target cluster size constant within a particular
survey [4]. Typically 50–100 clusters are selected,
depending on the total sample size required. Sample
size is calculated with the aim of estimating the
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gible individuals with 20-25% relative precision [4].
In most surveys that have already been completed,
participation of eligible individuals has been of the
order of 85%-95%, with typically lower participation
in urban areas. Most surveys use stratification,
to ensure that the number of clusters allocated to
each stratum is in proportion to the population in
that stratum. For example, the Philippines 2007 sur-
vey had three strata (urban, rural, and the capital
city) [9].
There are 2 co-primary outcomes in a TB prevalence
survey: (1) smear-positive pulmonary TB and (2) bac-
teriologically-confirmed pulmonary TB (smear-positive
and/or culture-positive). The TB case definition, and the
screening strategy used to identify pulmonary TB, in a
national-level prevalence survey are summarised in
Figure 3.
The number of individuals who were enumerated,
were eligible to participate, and who participated at vari-
ous stages of the survey should be summarised, for ex-
ample as depicted in Figure 4.
Before analysis of the two co-primary outcomes is
done, it is essential to describe the completeness and in-
ternal consistency of the “core” data i.e. the data that it
is essential to collect in all TB prevalence surveys. This
is covered in detail in the WHO handbook [4].Figure 3 TB case definition, and screening strategy for pulmonary TBIndividual-level analysis of pulmonary TB prevalence:
description and explanation of three alternative methods
The two outcomes of smear-positive pulmonary TB and
bacteriologically-confirmed pulmonary TB should be
analysed separately. Here, we illustrate methods for an
individual-level analysis using the outcome of bacterio-
logically-confirmed pulmonary TB, which we will refer
to hereafter as pulmonary TB. It should be noted that
the analytical approach would also be the same for other
outcomes that are binary (yes or no), for example TB di-
agnosed using the recently endorsed molecular test
Xpert MTB/RIF [18].
Individual-level analyses of pulmonary TB prevalence are
performed using logistic regression, in which the log odds,
i.e. log πij1−πij
 
is modelled, where πij is the probability of in-
dividual i in cluster j being a prevalent pulmonary TB case.
The simplest model that can be fitted is α ¼ log πij1−πij
 
, in
which case α is estimated as α ¼ log p1−p
 
, where p is the
observed overall proportion of study participants with
pulmonary TB. Correspondingly p ¼ exp αð Þ1þ exp αð Þ : Logistic
regression is used because the outcome is binary i.e. for
each individual there is a probability that they have pul-
monary TB at the time of the cross-sectional survey (in
the generalised linear models framework, the logistic link
function is the “natural link function”). The most crucial.
Figure 4 Survey participant flow. Schematic of numbers of participants screened for TB in the prevalence survey according to survey protocol.
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count the clustering of individuals: if this is not done, the
calculated 95% confidence interval (CI) for true pulmonary
TB prevalence will have less than the nominal 95% cover-
age, due to underestimation of the standard error of the
prevalence estimate.Two types of logistic regression model are recommended
for the analysis of a TB prevalence survey, both of which
allow for the clustering in the sampling design. These are:
(1) logistic regression, with robust standard errors calcu-
lated from observed between-cluster variability and (2)
random-effects logistic regression, in which a parameter
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is included in the probability model.
Random-effects logistic regression models may be pre-
ferred for quantifying the association between risk factors
and pulmonary TB prevalence, because they provide a full
probability model for the data including the between-
cluster variability in true TB prevalence. However, the esti-
mation process used in these models produces a
“shrunken” point estimate of the overall nationwide pul-
monary TB prevalence that is too low because it is calcu-
lated as a geometric, and not arithmetic, mean of the
observed cluster-specific prevalence values. Therefore, ro-
bust standard error logistic regression models, which are
“population-average” models within a generalised estimat-
ing equations framework, are preferred for the overall esti-
mation of nationwide pulmonary TB prevalence.
To estimate overall pulmonary TB prevalence, it is
recommended to use 3 methods of analysis in total, one of
which does not account for missing data and two of which
attempt to correct for bias due to missing data. In Figure 5,
we place all three methods within the framework set out
in a recent paper that considers the combination ofFigure 5 Methods 1-3, placed within a conceptual framework for ana
missing data.inverse probability weighting (IPW) and multiple imput-
ation (MI), with the analysis divided into two stages [17].
Method 1 is equivalent to CC/CC (complete-case ap-
proach for both Stage 1 and Stage 2), Method 2 is MI/MI,
to indicate it relies completely on multiple missing value
imputation, and Method 3 is IPW/MI, to indicate it com-
bines inverse probability weighting (for Stage 1) with mul-
tiple imputation (for Stage 2).
Method 1 (complete-case or CC/CC)
This method uses a logistic regression model with robust
standard errors, no missing value imputation, and analysis
is restricted to survey participants (=N2 in Figure 4), and
also excludes individuals who were eligible for sputum
examination but smear and/or culture results are missing.
Individuals who were not eligible for sputum examination
are assumed not to have pulmonary TB, unless their chest
X-ray was later found to be suggestive of TB based on a
reading at “central level” by an experienced radiologist –
in which case they are also excluded from the analysis.
The model does not account for variation in the number
of individuals per cluster, or correlation among individualslytical methods that attempt to correct for bias introduced by
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of pulmonary TB. Equal weight is given to each participat-
ing individual in the sample. However, the model does
correct for clustering (by using the observed between-
cluster variation) when estimating the 95% CI, and can
control for stratification in the sampling design. This
method corresponds to a classical individual-level analysis
of a survey, in the case that one does not need to adjust
for sampling weights. TB prevalence surveys are designed
to be “self-weighted”, with each individual in the popula-
tion having the same probability of selection into the sam-
ple [4] and thus the same “weight” in the analysis. Among
participants, this method always underestimates true
TB prevalence – because data on pulmonary TB are
missing only among individuals who were eligible for
sputum examination, who have a relatively higher
probability of being a TB case compared with those
not eligible. Differential participation in the survey by
cluster, age group, and sex may either exacerbate or
reduce this bias.
Method 2 (MI/MI)
This method uses a logistic regression model with robust
standard errors, with missing value imputation for sur-
vey non-participants as well as participants, and includes
all individuals who were eligible for the survey in the
analysis (=N1 in Figure 4). Multiple missing value imput-
ation (additional details below) is used for all individuals:
a) without a field chest X-ray result and/or symptom
screening – which includes all individuals who did not
participate in the survey, b) with a field chest X-ray
reading that the survey protocol stated should also be
read at central level, but missing the central reading, c)
eligible for sputum examination but whose status as a
pulmonary TB case is unknown due to missing smear
and/or culture results and d) ineligible for sputum
examination, but with a central X-ray reading that
was suggestive of TB, whose status as a pulmonary
TB case is thus unknown. This method allows for
both the clustering in the sampling design and the
uncertainty introduced by imputation of missing
values when estimating the 95% CI for the prevalence
of pulmonary TB.
Method 3 (IPW/MI)
The third method is also a logistic regression model with
robust standard errors, with missing value imputation
done among the subset of survey participants who were
eligible for sputum examination but for whom smear
and/or culture results were missing, and inverse prob-
ability weighting applied to all survey participants. This
method aims to represent the whole of the survey eli-
gible population (=N1 in Figure 4), but the weights are
applied only to individuals who participated in thesurvey. An individual is considered to have participated
in the survey if they were screened by both chest X-ray
and symptoms, or they refused or were exempted from
X-ray screening but provided sputum samples for TB
diagnosis (=N5 in Figure 4). Missing value imputation is
used for individuals eligible for sputum examination
(=N6 in Figure 4), plus individuals who were not eli-
gible for sputum examination but whose chest X-ray
was read as suggestive of TB at central level, for whom
data on one or more of the central chest X-ray reading,
symptom questions, and smear and/or culture results
were not available. Inverse probability weighting is then
used to correct for differentials in participation in the
survey by age, sex, and cluster. This is considered the
“safer” method compared with Method 2 because a
smaller amount of missing data is imputed. This means
that if the imputation model is miss-specified, the bias
in the resulting estimates will be smaller.
Missing value imputation: key concepts in the context of
TB prevalence surveys
Three main types of missing data mechanism have been
distinguished in the literature [7,8]; we explain them
below in the context of data being missing for the pri-
mary outcome variable, prevalent pulmonary TB.
(i) Missing completely at random (MCAR): no
adjustment required
Data are MCAR if the probability that an individual
has missing data on the outcome, pulmonary TB, is
NOT related to either a) the value of the outcome
(that is, TB case yes or no) or b) an individual
characteristic that is a risk factor for the outcome
(for example age, sex, stratum, cluster, TB
symptoms). In this case, analysis can be restricted to
individuals who DO participate fully in the survey,
and an unbiased estimate of the true overall
prevalence of pulmonary TB in the population will
be obtained. In other words, the (probabilistic)
sampling design itself automatically allows for
“completely at random” missing data.
(ii) Missing at random (MAR): missing value
imputation required
In the context of a TB prevalence survey, data are
MAR if two conditions are fulfilled. First, the
probability that an individual has missing data for the
outcome variable of pulmonary TB (yes or no) is
related to individual characteristics such as age, sex,
stratum, TB symptoms, and the field chest X-ray
reading. Second, within groups of individuals who are
the same for age, sex, stratum, TB symptoms, and
field chest X-ray reading, the probability of data being
missing on the outcome variable is not associated with
its value (that is, pulmonary TB case yes or no).
Floyd et al. Emerging Themes in Epidemiology 2013, 10:10 Page 8 of 13
http://www.ete-online.com/content/10/1/10If data are MAR, the observed prevalence of
pulmonary TB can be used to predict TB (yes or no)
for individuals for whom data are missing, provided
this is done with stratification on at least an
individual’s age, sex, area of residence, TB
symptoms, and field chest X-ray reading. Having
done this, an unbiased estimate of the true overall
prevalence of pulmonary TB in the population can
be obtained.
(iii)Missing not at random (MNAR): missing value
imputation and also sensitivity analysis required
Data are MNAR if the probability of an individual
having missing data on the outcome variable (that is,
TB case yes or no) is different for individuals who
have pulmonary TB compared with individuals who
do not have pulmonary TB, even after post-
stratification of individuals using characteristics that
are known to be risk factors for pulmonary TB (such
as area of residence, age, sex). If data are MNAR, it
is not possible to correct the estimate of pulmonary
TB prevalence simply by using missing value
imputation based on the patterns in the observed
data. Instead, a sensitivity analysis is required (see
below), which is an area of on-going research [19].
The observed data themselves cannot be used to dis-
tinguish between MAR and MNAR. Missing value im-
putation is implemented under the assumption that data
are MAR.
Missing value imputation: recommended approach to
implementation
Method 2
In a TB prevalence survey, it is usually the case (based
on experience to date) that age, sex, stratum, and cluster
are known for all (or almost all) eligible individuals,
while there will be missing data on TB symptoms, field
and central chest X-ray readings, smear and culture re-
sults, and the primary outcome of pulmonary TB.
It is essential to start by exploring the extent to which
data are missing, in order to understand the possible
biases that may result from an analysis that is restricted
to survey participants and to choose imputation models
that make the MAR assumption plausible. The following
three variables should be summarized: the proportion of
eligible individuals who participated in the symptom and
chest X-ray screening; the proportion of those with two
sputum samples among people eligible for sputum
examination; and the proportion with smear and culture
results from 0, 1 or 2 sputum samples. These summaries
should be done overall, and be broken down by individ-
ual risk factors for pulmonary TB such as age group, sex
and stratum – in order to know which individual charac-
teristics are predictors of missingness.Missing value imputation is done using regression
models in a procedure called “imputation by chained
equations”, and can be implemented using standard stat-
istical software packages such as Stata, SAS, and R
[20-22]. For example, in the statistical package Stata this
is done using the ice (“imputation by chained equations”)
command [23]. Additional file 1 explains, step-by-step,
how the imputation is implemented to create a single
imputed dataset. As recently set out in a paper that
provides general guidance on the use of multiple im-
putation [16], key principles to observe when specifying
the imputation model are: (1) it must include all ex-
planatory variables to be investigated as risk factors at
the analysis stage, and the outcome variable itself; (2)
to make the MAR assumption plausible it “should in-
clude every variable that both predicts the incomplete
variable and predicts whether the incomplete variable
is missing”; (3) including variables that are predictors of
the incomplete variable, whether or not they also pre-
dict missingness, will give better imputations; and (4)
including variables that are predictors of missingness,
whether or not there is statistical evidence they are pre-
dictors of the incomplete variable, helps to limit the po-
tential for bias.
Our recommendation, following from this, is as fol-
lows. The outcome variable in a TB prevalence survey is
pulmonary TB; sputum smear and culture results, the
field and central chest X-ray reading, and TB symptoms
are used in combination to define if an individual has
pulmonary TB (see Additional file 1 for more detail).
Thus all of these variables must be included in the im-
putation models. Individual characteristics that are
established predictors of pulmonary TB (e.g. age, sex)
and/or predictive of data being missing (e.g. age, sex,
stratum) should be considered for inclusion in the imput-
ation models, as illustrated in Additional file 1. The stron-
gest predictors of pulmonary TB and/or missingness (age,
sex, stratum) should always be included in the imputation
models for TB symptoms, field X-ray reading, and smear
and culture positivity. At the same time, the choice of add-
itional predictors (e.g. smoking and alcohol consumption)
may need to be limited so as to avoid severe collinearity,
especially when imputing smear and culture results and
the number of positive smear and culture results is
small (though because imputation models are being
used for predictive purposes, moderate collinearity is
not problematic). Including cluster as an explanatory vari-
able in the imputation model with smear positivity (yes or
no) as the outcome variable is not recommended, because
the number of individuals with a positive smear result is
low relative to the number of clusters; this is true also for
the imputation model with culture positivity (yes or no) as
the outcome variable. For outcomes that are more com-
mon, such as abnormal chest X-ray result (yes or no),
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ation model may be appropriate.
The process described in Additional file 1 is repeated to
create, for example, 10–20 imputed datasets (hence the
terminology “multiple” missing value imputation). The
number of imputed datasets should be greater than or
equal to the percentage of eligible individuals for whom
data are missing [16]. To date, this percentage has been in
the range 4-15% in TB prevalence surveys, and we recom-
mend that at least 20 imputed datasets are created.
The overall prevalence of pulmonary TB is calculated
for each imputed dataset. The national-level pulmonary
TB prevalence estimate is then calculated as the average
of the pulmonary TB prevalence values from each im-
puted dataset, with a 95% CI that takes into account
both the sampling design and the uncertainty due to
missing value imputation. In Stata, this can be done
using the mim or mi commands [23].
Method 3
Multiple imputation is an efficient method for accounting
for missing data, provided the imputation models are speci-
fied appropriately [8,16,24]. An alternative approach is to
use a combination of multiple imputation (MI) and inverse
probability weighting (IPW) [17]. With this approach, im-
putation is used to fill in missing values only among indi-
viduals who participated fully in the survey (N5 in Figure 4).
Survey participants can be divided into two groups,
eligible or ineligible for sputum examination. Individuals
who were ineligible for sputum examination are as-
sumed not to have pulmonary TB, unless they had a
normal field chest X-ray reading but an abnormal cen-
tral chest X-ray reading. For those eligible for sputum
examination (N6 in Figure 4, and additionally individuals
with a normal field chest X-ray reading but abnormal
central chest X-ray reading), multiple imputation is used
to fill in missing data, in exactly the same way as de-
scribed for Method 2 above (including using the same
variables in the imputation models). Each of the imputed
datasets is then combined with the data on individuals
who were ineligible for sputum examination, to give (for
example) 20 imputed datasets that include all individuals
who participated fully in the survey.
For each imputed dataset, a point estimate and 95% CI
for population pulmonary TB prevalence is then calcu-
lated, using logistic regression with robust standard
errors and weights. Weights are calculated for each
combination of cluster, age group, and sex. This is done
by a) counting the number of eligible individuals in each
combination of cluster, age group, and sex (Nijk, for clus-
ter i, age group j, sex k) and b) counting the number of
survey participants in each combination of cluster, age
group, and sex (nijk). The weight for each individual is
then equal to Nijk / nijk, for the particular combinationof cluster/age group/sex that they are in, with nijk / Nijk
being the probability that the sampled individual partici-
pates in the survey – hence the name “inverse probabil-
ity weighting”. It is essential to include either the
weights or the covariates that predict the weights in the
imputation model [17]. We include age group, sex, and
stratum (area of residence) in all imputation models. An
average of the estimates of pulmonary TB prevalence
from each of the imputed datasets is then calculated, to-
gether with a 95% CI. In Stata, this can be done using
the mim and svy commands.
An advantage of using IPW combined with MI, rather
than just MI, is that it is relatively simple and transpar-
ent to calculate the probability of survey participation by
cluster, age group and sex, compared with adjusting for
non-participation through the use of a multivariable im-
putation model [17,24]. However, an important assump-
tion remains, which is that after post-stratifying on
cluster, age, and sex, the prevalence of pulmonary TB is
the same in survey participants and non-participants.
Comparing results across Methods 1–3
If point estimates of pulmonary TB prevalence and their
confidence intervals vary greatly among Methods 1–3, it
is essential to try to understand the reasons for the dif-
ferences and the results of the survey should be
interpreted within these limitations. Method 1 intro-
duces biases, as explained above, so it is not surprising if
it provides a prevalence estimate that is different to the
one obtained from Methods 2 and 3. If the prevalence
estimates from Methods 2 and 3 are considerably differ-
ent, this may be due to misspecification of the imput-
ation models used in Method 2.
Sensitivity analysis: a simple method
A simple way to implement a sensitivity analysis is to
use as a starting point the imputed datasets that were
created using Method 2.
For an “extreme” situation in which there are 0 pulmon-
ary TB cases among non-participants, the prevalence of
pulmonary TB is estimated simply as the observed num-
ber of pulmonary TB cases divided by the total eligible
survey population. For an opposite “extreme” in which the
risk of pulmonary TB is twice as high among non-
participants as in participants (within sub-groups defined
by stratum, age group, sex, and other variables included in
the imputation model for pulmonary TB), the number of
pulmonary TB cases among non-participants is estimated
for each imputed dataset as 2ti, where ti is the number of
pulmonary TB cases that were imputed in the ith imputed
dataset. Then the overall pulmonary TB prevalence is cal-
culated as the average of the 2ti values, plus the number of
pulmonary TB cases among survey participants, divided
by the total eligible survey population.
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Simulation studies were done for 4 plausible scenarios
through which missing data could be generated in TB
prevalence surveys. We explored missingness of data on the
outcome of prevalent TB by age, sex, stratum and cluster.
We chose these four variables on the basis that they are as-
sociated both with the outcome and the reason for
missingness [16]. Across the 50 clusters in the 2007
Philippines survey, the minimum number of individuals
aged ≥10 years old for whom data on all of age, sex, stratum
(urban, rural, the capital city), cluster, field and chest X-ray
reading, TB symptoms, and smear and culture results, were
complete was 190. In order to create a dataset in which the
number of individuals in each cluster was the same, all TB
cases in each cluster and a random sample of non-TB cases
were selected to create a dataset of 9500 individuals, i.e. 190
in each of 50 clusters. In this dataset, TB prevalence was
1263 per 100,000 (120/9500).
Missing values were then introduced into this dataset to
create 1000 datasets with missing data on the field chest
X-ray reading and TB symptoms, and smear and culture
results, for each of the following 4 scenarios:
1. Differential participation by age group, sex, and
stratum (n = 3), with overall participation
approximately 90%; 15% of smear and culture results
missing completely at random among individuals
eligible for sputum examination; overall, 19% of eligible
individuals with missing data on pulmonary TB.
2. Differential participation by age group, sex, and
cluster (n = 50), with overall participation
approximately 90%; 15% of smear and culture resultsTable 1 Prevalence of pulmonary TB (per 100,000 population
Prevalence (95% CI) Cluster-level Me
Overall point prevalence 663 (516–810) 660
Point prevalence by stratum4
Metro Manila 671 (238–1105) 670
Other urban 671 (421–921) 660
Rural 655 (447–863) 660
Overall crude 5 prevalence
Stratum crude5 prevalence
Metro Manila
Other urban
Rural
1Robust standard errors.
2Robust standard errors with missing value imputation.
3Robust standard errors with missing value imputation and inverse probability weig
4Stratum-specific estimates are calculated from an overall regression model includin
the model.
5Crude prevalence is calculated as the total number of individuals with a positive sm
been screened for TB by chest X-ray and/or interview. Confidence interval for this emissing completely at random among individuals
eligible for sputum examination; overall, 20% of
eligible individuals with missing data on pulmonary
TB.
3. As for 2, but among individuals eligible for sputum
examination, the probability of missing smear and
culture results varied among the 3 strata; overall,
20% of eligible individuals with missing data on
pulmonary TB.
4. As for 2, but among individuals eligible for sputum
examination the probability of missing smear and
culture results varied among the 50 clusters; overall,
20% of eligible individuals with missing data on
pulmonary TB.
Results
An example analysis using the dataset from the 2007
survey in the Philippines
To illustrate the 3 methods of analysis outlined above,
we use the 2007 national TB prevalence survey in the
Philippines. In this example, the eligible survey popula-
tion was individuals aged ≥10 years old, which is differ-
ent from the current WHO recommendation for the
survey population to consist of individuals aged ≥15 years
old [4]. However, the analytical approach and presenta-
tion of results remain the same.
Overall, participation was high at 90% of eligible indi-
viduals, though it was higher in rural and urban areas
than in the capital city, lower among 20–39 year olds
than other age groups, and the age-pattern of survey
participation differed between men and women (data
not shown). Additional details about the survey are pro-
vided elsewhere [9].) in the Philippines 2007 national TB prevalence survey
thod 11 Method 22 Method 33
(520–810) 660 (530–800) 680 (530–830)
(100–1240) 640 (160–1120) 710 (100–1320)
(470–860) 680 (500–860) 700 (490–910)
(450–870) 650 (460–850) 660 (440–870)
n / N (Prevalence, 95% CI)
136/20 544 (660, 560–780)
15/2253 (670, 370–1100)
50/7519 (660, 490–880)
71/10,772 (660, 520–830)
hting.
g all clusters and all individuals, with stratum fitted as a fixed-effect in
ear and/or culture result divided by the total number of individuals who have
stimate is calculated with exact binomial probability theory.
Figure 6 Distribution of cluster-level prevalence of
bacteriologically-confirmed pulmonary TB among 50 clusters,
Philippines, 2007.
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Results for the prevalence of pulmonary TB are summarised
in Table 1, and the observed distribution of cluster-level pul-
monary TB prevalence is shown in Figure 6. From the
cluster-level analysis, the estimate of the prevalence of pul-
monary TB is 663 per 100,000 population, with a 95% confi-
dence interval of [516–810], with Method 1 giving an
almost identical estimate and 95% confidence interval.
Method 2 gives the same point estimate of pulmonary TB
prevalence but with a slightly narrower confidence interval.
The point prevalence estimate of pulmonary TB from
Method 3, combining multiple imputation with inverse
probability weighting, is slightly higher than the estimates
from Methods 1 and 2, at 680 per 100,000 and with a
slightly wider confidence interval.
Among survey participants, multiple imputation of missing
smear and culture results increases the estimate of the preva-
lence of pulmonary TB from 660 to 670 per 100,000. This is
a relatively small increase, reflecting that among individuals
eligible for sputum examination the proportion with missing
data on smear and/or culture results was very low. UsingTable 2 Simulation study results, for 4 scenarios of how missi
Method 11
Mean (SD)4 Relative bias (%)5 Mean (SD)4
Scenario 1 1143 (60.0) −10 1276 (65.5)
Scenario 2 1144 (64.0) −9 1279 (70.4)
Scenario 3 1139 (65.0) −10 1278 (71.4)
Scenario 4 1144 (64.8) −9 1281 (71.2)
1Robust standard errors.
2Robust standard errors with missing value imputation.
3Robust standard errors with missing value imputation and inverse probability weig
4Mean estimate of pulmonary TB prevalence (per 100,000 population aged ≥10 yea
TB prevalence estimates. The true value of TB prevalence in these data was 1263 pe
5The relative bias is defined as the percentage = (mean-true)/true. Negative values i
simulated series of data.inverse probability weighting to account for differentials in
survey participation by cluster, age group, and sex increases
the prevalence estimate from 670 to 680 per 100,000.
Overall, the cluster-level analysis and the results from each
of Methods 1, 2, and 3 show that the best estimate of pul-
monary TB prevalence is of the order of 660 – 680 per
100,000 population among individuals aged ≥10 years old,
with the coverage of the 95% CIs ranging from 516 to 830
per 100,000 population.
Sensitivity analysis
A sensitivity analysis in which pulmonary TB prevalence
among non-participants ranges from 0 to being twice as
high as among participants, gives a range of the point
estimate of pulmonary TB prevalence from 595 to 731
per 100,000 population, compared with the estimate
from Methods 1 and 2 of 660 per 100,000.
Simulation studies to assess the performance of Methods
1–3: results
For all of scenarios 1–4, we analysed each of the 1000
datasets using Methods 1, 2 and 3. For both Methods 2
and 3, 20 imputed datasets were created for each of the
1000 “starting” datasets. Simulation results showed that
for all 4 scenarios, Method 1 underestimated TB preva-
lence by an average of approximately 9%, with preva-
lence estimates lower than the true value of 1263 per
100,000 for 97% of the Scenario 4 simulations. Method 2
overestimated TB prevalence by an average of around
1.5%, while Method 3 estimated TB prevalence to an
average that was within 1% of the true value. Details of
the results are summarised in Table 2 and Figure 7.
Conclusions
We recommend that the method that uses the cluster as the
unit of analysis should remain the first step in the analysis of
a TB prevalence survey [6], as it is a simple method of ana-
lysis that has the advantage of being very transparent. It also
requires a careful description of the variation in observed
cluster-level pulmonary TB prevalence, which is anng data could arise in a prevalence survey
Method 22 Method 33
Relative bias (%)5 Mean (SD)4 Relative bias (%)5
1.0 1273 (66.0) 0.8
1.3 1270 (70.1) 0.6
1.2 1269 (71.8) 0.5
1.4 1272 (71.7) 0.7
hting.
rs old), over 1000 simulations, and standard deviation of the 1000 pulmonary
r 100,000 population.
ndicate under-, positive values over-, estimation of the true prevalence by the
0
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Figure 7 Density plots of simulated data series. Density plots of the distribution of prevalence estimates calculated from simulation study
data series. Dashed vertical line represents the “true” level of prevalence.
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http://www.ete-online.com/content/10/1/10important feature of the data that should be described well
and summarized graphically. However, it has exactly the
same limitations in terms of bias as an individual
“complete-case” analysis (Method 1). In our simulation
studies, Method 1 underestimated TB prevalence by an
average of about 9%. It is thus essential that a cluster-
level analysis is followed by individual-level analyses,
initially restricted to individuals for whom data on the
primary outcome of pulmonary TB is complete (a
“complete-case analysis”), and then extended through
missing value imputation to include all eligible
individuals.
Following a general recommendation [7], it is important
to present both the complete-case analysis (Method 1)
and an analysis that attempts to correct for bias intro-
duced by missing data. Following recent work on using a
combination of IPW and MI [17], it is also recommended
to always compare the approach that uses multiple imput-
ation for all eligible individuals (Method 2) with the more
conservative approach that uses multiple imputation only
among survey participants and uses IPW to account for
differences between participants and non-participants
(Method 3). Our simulation studies show that Methods 2
and 3 both perform well, but that Method 3 is slightly
better.
Overall, we recommend Method 3, inverse probability
weighting combined with multiple imputation of missing
data among individuals eligible for sputum examination, asthe method that provides the safest approach and the sin-
gle best estimate of population pulmonary TB prevalence.
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Additional file 1: Multiple missing value imputation for analysis of
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